Cargando…
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer
Colorectal cancer (CRC) is now the second-leading cause of cancer deaths in the USA. Colorectal cancer progression and metastasis depends on the orchestration of the aberrant signaling pathways that control tumor cell proliferation, survival and migration/invasion. Epidemiological, clinical, and ani...
Autores principales: | Wang, Dingzhi, Xia, Dianren, DuBois, Raymond N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763401/ https://www.ncbi.nlm.nih.gov/pubmed/24213116 http://dx.doi.org/10.3390/cancers3043894 |
Ejemplares similares
-
Prostaglandin E(2) promotes intestinal tumor growth via DNA methylation
por: Xia, Dianren, et al.
Publicado: (2012) -
Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
por: Wang, Dingzhi, et al.
Publicado: (2008) -
Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014) -
Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis
por: Vogel, Lotte K., et al.
Publicado: (2014) -
Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer
por: Cen, Bo, et al.
Publicado: (2021)